Medicines and Healthcare products Regulatory Agency

Issued following an inspection in accordance with :

Part 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 (SI 2004/1031)

  The competent authority of United Kingdom confirms the following :    

Has been inspected under the national inspection programme in connection with manufacturing authorisation no. UK MIA(IMP) 4351 in accordance with Part 6 of The Medicines for Human Use (Clinical Trials) Regulations 2004 (SI 2004/1031)

From the knowledge gained during inspection of this manufacturer, the latest of which was conducted on 28/03/2022, it is considered that it complies with

• The principles and guidelines of Good Manufacturing Practice laid down in Regulation B17 of the Human Medicines Regulations 2012 (as amended)

This certificate reflects the status of the manufacturing site at the time of the inspection noted above and should not be relied upon to reflect the compliance status if more than three years have elapsed since the date of that inspection. However, this period of validity may be reduced or extended using regulatory risk management principles by an entry in the Restrictions or Clarifying remarks field. This certificate is valid only when presented with all pages and both Parts 1 and 2. The authenticity of this certificate may be verified in MHRA-GMDP. If it does not appear, please contact the issuing authority.

---

Operations

1. MANUFACTURING OPERATIONS

[ 1.1 ] Sterile Investigational Medicinal Products

[ 1.1.3 ] Batch certification

[ 1.2 ] Non-sterile investigational medicinal products

[ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms)

[ 1.2.1.1 ] Capsules, hard shell Inclusion of Potent, Toxic Compounds

[ 1.2.1.5 ] Liquids for external use Inclusion of Potent, Toxic Compounds

[ 1.2.1.6 ] Liquids for internal use Inclusion of Potent, Toxic Compounds

[ 1.2.1.11 ] Semi-solids Inclusion of Potent, Toxic Compounds

[ 1.2.1.12 ] Suppositories Inclusion of Potent, Toxic Compounds

[ 1.2.1.13 ] Tablets Inclusion of Potent, Toxic Compounds

[ 1.2.1.17 ] Other non-sterile medicinal products Capsules Hard Shell - encapsulation of cytotoxic tablets, Filling of Powders.

[ 1.2.2 ] Batch certification

[ 1.4 ] Other products or manufacturing activity

[ 1.4.1 ] Manufacture of:

[ 1.4.1.1 ] Herbal products

[ 1.5 ] Packaging

[ 1.5.1 ] Primary packaging

[ 1.5.1.1 ] Capsules, hard shell Inclusion of Potent, Toxic Compounds

[ 1.5.1.5 ] Liquids for external use Inclusion of Potent, Toxic Compounds

[ 1.5.1.6 ] Liquids for internal use Inclusion of Potent, Toxic Compounds

[ 1.5.1.11 ] Semi-solids Inclusion of Potent, Toxic Compounds

[ 1.5.1.12 ] Suppositories Inclusion of Potent, Toxic Compounds

[ 1.5.1.13 ] Tablets Inclusion of Potent, Toxic Compounds

[ 1.5.1.17 ] Other non-sterile medicinal products Filling of powders. Capsule hard shells encapsulation of cytotoxic tablets

[ 1.5.2 ] Secondary packaging

[ 1.6 ] Quality control testing

[ 1.6.2 ] Microbiological: non-sterility

[ 1.6.3 ] Chemical/Physical

2. IMPORTATION OF MEDICINAL PRODUCTS

[ 2.1 ] Quality control testing of imported medicinal products

[ 2.1.2 ] Microbiological: non-sterility

[ 2.1.3 ] Chemical/Physical

[ 2.2 ] Batch certification of imported medicinal products

[ 2.2.1 ] Sterile Products

[ 2.2.1.1 ] Aseptically prepared

[ 2.2.1.2 ] Terminally sterilised

[ 2.2.2 ] Non-sterile products

[ 2.2.3 ] Biological medicinal products

[ 2.2.3.1 ] Blood products

[ 2.2.3.2 ] Immunological products

[ 2.2.3.5 ] Biotechnology products

[ 2.2.3.6 ] Human or animal extracted products

[ 2.3 ] Other Importation Activities

[ 2.3.1 ] Site of Physical Importation

[ 2.3.2 ] Importation of Intermediate which undergoes further processing

Contact Details

17/05/2022	Name and signature of the authorised person of the Competent Authority of United Kingdom
	Confidential
	Medicines and Healthcare products Regulatory Agency
	Tel : Confidential